Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021)
Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | -0.50% |
| 10 | Nu-Med Plus | 1.70 Mn | 1.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -92.06% |
| Dec 31, 2020 | -91.79% |
| Sep 30, 2020 | 4,170.48% |
| Jun 30, 2020 | 2,016.51% |
| Mar 31, 2020 | 1,304.92% |
| Dec 31, 2019 | 421.17% |
| Sep 30, 2019 | -78.00% |
| Jun 30, 2019 | -63.35% |
| Mar 31, 2019 | -52.92% |
| Dec 31, 2018 | 9.78% |
| Sep 30, 2018 | -39.07% |
| Jun 30, 2018 | -34.24% |
| Dec 31, 2012 | 2,164.71% |